pH dependent efflux of methamphetamine derivatives and their reversal through human Caco-2 cell monolayers

European Journal of Pharmacology

Volumn 592, Issue 1-3, 2008, Pages 7-12

  Crowe, Andrew ^a   Diep, Susanna ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Epinephrine; MDEA; MDMA; Noradrenalin; p MA; Reserpine

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 METHOXYAMPHETAMINE; ADRENALIN; BUCLADESINE; CALMIDAZOLIUM; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; DEXAMPHETAMINE; DOPAMINE TRANSPORTER; ELACRIDAR; EXTRANEURONAL MONOAMINE TRANSPORTER; GLYCOPROTEIN P INHIBITOR; HISTAMINE; LEVODOPA; METHAMPHETAMINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; NIFEDIPINE; NORADRENALIN; ORGANIC CATION TRANSPORTER; PARAQUAT; PHENIRAMINE; PSEUDOEPHEDRINE; RESERPINE; SODIUM AZIDE; SODIUM PROTON EXCHANGE PROTEIN; TETRYLAMMONIUM; THEOPHYLLINE; UNCLASSIFIED DRUG; VALSPODAR; VANADATE SODIUM; VANADIC ACID;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL PH; CELL STRAIN CACO 2; CONTROLLED STUDY; DIFFUSION; DRUG TRANSPORT; HUMAN; HUMAN CELL; METABOLIC INHIBITION; MONOLAYER CULTURE; PRIORITY JOURNAL;

AMILORIDE; BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINS; DIURETICS; EPINEPHRINE; FLUORESCENT DYES; HUMANS; HYDROGEN-ION CONCENTRATION; METHAMPHETAMINE; NOREPINEPHRINE; P-GLYCOPROTEIN;

EID: 49749120960     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.06.090     Document Type: Article

References (37)

1. Amphoux A., Vialou V., Drescher E., Bruss M., Mannoury La Cour C., Rochat C., Millan M.J., Giros B., Bonisch H., and Gautron S. Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 50 (2006) 941-952
2. Artursson P. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 79 (1990) 476-482
3. Bailey C., Bryla P., and Malick A. The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development. Adv. Drug Deliv. Rev. 22 (1996) 85-103
4. Bertelsen K.M., Greenblatt D.J., and von Moltke L.L. Apparent active transport of MDMA is not mediated by P-glycoprotein: a comparison with MDCK and Caco-2 monolayers. Biopharm. Drug Dispos. 27 (2006) 219-227
5. Blackmore C.G., Varro A., Dimaline R., Bishop L., Gallacher D.V., and Dockray G.J. Measurement of secretory vesicle pH reveals intravesicular alkalinization by vesicular monoamine transporter type 2 resulting in inhibition of prohormone cleavage. J. Physiol. 531 (2001) 605-617
6. Calhau C., Martel F., Hipolito-Reis C., and Azevedo I. Effect of thiamine on 3H-MPP+ uptake by Caco-2 cells. Pharmacol. Res. 48 (2003) 579-584
7. Crowe A., Ilett K.F., Karunajeewa H.A., Batty K.T., and Davis T.M. Role of P glycoprotein in absorption of novel antimalarial drugs. Antimicrob. Agents Chemother. 50 (2006) 3504-3506
8. Crowe A., and Lemaire M. In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin. Pharm. Res. 15 (1998) 1666-1672
9. Crowe A., and Teoh Y.K. Limited P-glycoprotein mediated efflux for anti-epileptic drugs. J. Drug Target. 14 (2006) 291-300
10. Crowe A., and Wong P. pH dependent uptake of loperamide across the gastrointestinal tract: an in vitro study. Drug Dev. Ind. Pharm. 30 (2004) 449-459
11. Fraga S., Sampaio-Maia B., Serrao M.P., and Soares-da-Silva P. Regulation of apical transporter of L-DOPA in human intestinal Caco-2 cells. Acta Physiol. Scand. 175 (2002) 103-111
12. Friedgen B., Wolfel R., Russ H., Schomig E., and Graefe K.H. The role of extraneuronal amine transport systems for the removal of extracellular catecholamines in the rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol. 354 (1996) 275-286
13. Gan L., and Thakker D. Application of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium. Adv. Drug Deliv. Rev. 23 (1997) 77-98
14. Grasset E., Bernabeu J., and Pinto M. Epithelial properties of human colonic carcinoma cell line Caco-2: effects of secretagogues. Am. J. Physiol. 248 (1985) C410-C418
15. Han D.D., and Gu H.H. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol. 6 (2006) 6
16. Hidalgo I., Raub T., and Borchardt R. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96 (1989) 736-749
17. Hosoya K., Kim K., and Lee V. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers. Pharm. Res. 13 (1996) 885-890
18. Kanfer I., Dowse R., and Vuma V. Pharmacokinetics of oral decongestants. Pharmacotherapy 13 (1993) 116S-128S discussion 143S-146S
19. Ketabi-Kiyanvash N., Weiss J., Haefeli W.E., and Mikus G. P-glycoprotein modulation by the designer drugs methylenedioxymethamphetamine, methylenedioxyethylamphetamine and paramethoxyamphetamine. Addict. Biol. 8 (2003) 413-418
20. Kuwayama K., Inoue H., Kanamori T., Tsujikawa K., Miyaguchi H., Iwata Y., Miyauchi S., Kamo N., and Kishi T. Uptake of 3,4-methylenedioxymethamphetamine and its related compounds by a proton-coupled transport system in Caco-2 cells. Biochim. Biophys. Acta 1778 (2008) 42-50
21. Mann H., Ladenheim B., Hirata H., Moran T., and Cadet J. Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice. Brain Res. 769 (1997) 340-346
22. Monteiro R., Calhau C., Martel F., Faria A., Mateus N., and Azevedo I. Modulation of MPP+ uptake by tea and some of its components in Caco-2 cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 372 (2005) 147-152
23. Partilla J.S., Dempsey A.G., Nagpal A.S., Blough B.E., Baumann M.H., and Rothman R.B. Interaction of amphetamines and related compounds at the vesicular monoamine transporter. J. Pharmacol. Exp. Ther. 319 (2006) 237-246
24. Schomig E., Lazar A., and Grundemann D. Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency. Handb. Exp. Pharmacol. (2006) 151-180
25. Schwab M.E., and Thoenen H. Mechanism of uptake and retrograde axonal transport of noradrenaline in sympathetic neurons in culture: reserpine-resistant large dense-core vesicles as transport vehicles. J. Cell Biol. 96 (1983) 1538-1547
26. Seithel A., Karlsson J., Hilgendorf C., Bjorquist A., and Ungell A.L. Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells. Eur. J. Pharm. Sci. 28 (2006) 291-299
27. Silvestrini B., Palmery M., Basta F., and Valeri P. Facilitating effect of amphetamine on the response of rabbit aortic strips to adrenaline, dopamine and serotonin. J. Neural.Transm. Gen. sect. 86 (1991) 51-59
28. Soares M., Carvalho M., Remiao F., and Bastos M. Simultaneous determination of amphetamine derivatives in human urine after SPE extraction and HPLC-UV analysis. Biomed. Chromatogr. 18 (2004) 125-131
29. Sulzer D., and Rayport S. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5 (1990) 797-808
30. Till A.E., and Benet L.Z. Renal excretion of pseudoephedrine in the rat. J. Pharmacol. Exp. Ther. 211 (1979) 555-560
31. Tsuji A., and Tamai I. Carrier-mediated intestinal transport of drugs. Pharm. Res. 13 (1996) 963-977
32. Upreti V.V., and Eddington N.D. Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat. J. Pharm. Sci. 97 (2008) 1593-1605
33. Wang T.K., and Fuh M.S. Determination of amphetamine in human urine by dansyl derivatization and high-performance liquid chromatography with fluorescence detection. J. Chromatogr., B Biomed. Appl. 686 (1996) 285-290
34. Wu X., Whitfield L., and Stewart B. Atorvastatin transport in the Caco-2 cell model: contribution of P-glycoprotein and the proton-monocarboxylic acid co-transporter. Pharm. Res. 17 (2000) 209-215
35. Yamada H., Yamahara A., Yasuda S., Abe M., Oguri K., Fukushima S., and Ikeda-Wada S. Dansyl chloride derivatization of methamphetamine: a method with advantages for screening and analysis of methamphetamine in urine. J. Anal. Toxicol. 26 (2002) 17-22
36. Youdim K., Dobbie M., Kulhnle G., Proteggente A., Abbott N., and Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: in vitro studies. J. Neurochem. 85 (2003) 180-192
37. Zhu H.J., Wang J.S., DeVane C.L., Williard R.L., Donovan J.L., Middaugh L.D., Gibson B.B., Patrick K.S., and Markowitz J.S. The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine. Drug Metab. Dispos. 34 (2006) 1116-1121